Page 3 - Cross Labcell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cross labcell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cross Labcell Today - Breaking & Trending Today

GC Pharma Reports Q1 2021 Results

Press release content from Business Wire. The AP news staff was not involved in its creation.
GC Pharma Reports Q1 2021 Results
April 29, 2021 GMT
YONGIN, South Korea (BUSINESS WIRE) Apr 28, 2021
GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 31 March 2021.
First-Quarter Reported Results(1)

(2)
Financial Highlights
Delivered total revenue decline of 8.3% KRW 282.2 billion (2019 Q1: 307.8 billion), and operating profit decreased 18.0% to KRW 5.0 billion (2020 Q1: 6.1 billion) in the first quarter.
Unconsolidated revenues temporal setback due to termination of in-licence product distribution and vaccine’s international shipping schedule changes ....

South Korea , South Korean , Hyungoo Kang , Cross Labcell , Green Cross , Green Cross Corporation , Quarter Reported Results , Green Cross Labcell , Cross Corporation , Business Wire , தெற்கு கொரியா , தெற்கு கொரியன் , பச்சை குறுக்கு , பச்சை குறுக்கு நிறுவனம் , குறுக்கு நிறுவனம் , வணிக கம்பி ,

GC Pharma Reports Full Year 2020 Results

Press release content from Business Wire. The AP news staff was not involved in its creation.
GC Pharma Reports Full Year 2020 Results
February 9, 2021 GMT
YONGIN, South Korea (BUSINESS WIRE) Feb 9, 2021
GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited financial results for the year ended 31 December 2019.
Key Figures (1)
-
(1) Results from continuing operations (Green Cross MS’ blood bag business has been classified as discontinued operations)
(2) Results and percentages compare full financial year 2019
Financial Highlights
Delivered total revenue growth of 10.8% to KRW 1,504.1 billion (2019: 1,357.1 billion), and operation profit increased 20.6% to KRW 50.2 billion (2019: 41.7 billion) in the full year of 2020 ....

United States , South Korea , South Korean , Hyungoo Kang , Woosub Shin , Cross Labcell , Green Cross Corporation , Green Cross , Genef China , Cross Corporation , Business Wire , Corporate News , Pharmaceutical Manufacturing , Health Care Industry , East Asia , Earnings Reports , Medical Biotechnology Industry , Financial Performance , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , தெற்கு கொரியன் , பச்சை குறுக்கு நிறுவனம் , பச்சை குறுக்கு , குறுக்கு நிறுவனம் , வணிக கம்பி , பெருநிறுவன செய்தி ,